MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.

IYH: Diversified Healthcare ETF Suitable For Short Term Investment

04:24am, Tuesday, 03'rd May 2022 Seeking Alpha
The IYH ETF has posted strong price returns over the medium and long term, but generated 1% yield. Read why I'll prefer to make IYH a trading instrument.
On another difficult Friday afternoon for the stock market, the broad U.S. indexes ended with significant declines --- with tech stocks standing out.

Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline

07:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Welcome to part two of this three-part series. In part one, we looked at the importance of timing and identifying high-probability assets across all markets. In part two, we look at why being a good s

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

10:20am, Thursday, 21'st Apr 2022 Zacks Investment Research
Sector ETF report for PTH
A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.

Wall Street Thinks This Stock Has 50% Upside

10:20am, Thursday, 14'th Apr 2022 The Motley Fool
That prediction might be too conservative.

Wall Street Thinks This Stock Has 50% Upside

06:20am, Thursday, 14'th Apr 2022
That prediction might be too conservative.

IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists

02:46pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
U.S. indices fell Monday in anticipation of expected Fed rate hikes this year as the Fed seeks to curb inflation. A rise in bond yields has pressured technology and growth stock valuations. The 10-yea

Accuray's (ARAY) CyberKnife Effective for Relief From TN Pain

02:46pm, Monday, 04'th Apr 2022 Zacks Investment Research
Latest data indicates that Accuray's (ARAY) CyberKnife System is effective in providing long-lasting pain relief to patients suffering from TN.

3 Reasons to Retain Accuray (ARAY) Stock in Your Portfolio

03:12pm, Friday, 01'st Apr 2022 Zacks Investment Research
Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE